A novel liquid surface coating on human catheters could help reduce protein deposition that leads to urinary tract and bloodstream infections, according to researchers at the University of Maine and University of Notre Dame who are leading a study funded by the National Institutes of Health.
Share this article
Share this article
NATICK, Mass., May 25, 2021 /PRNewswire/ AffyImmune Therapeutics, Inc., a clinical stage biotechnology company finding safe, effective ways to use CAR T cells against solid cancers, announced today that co-founder and CEO Dr. Moonsoo Jin was awarded a Research Project Grant (R01). The grant,
CAR T Cells for Advanced Thyroid Cancer, will contribute to supportive studies related to AffyImmune s Phase 1 clinical trial,
Study of AIC100 in Relapsed/Refractory Thyroid Cancer at Weill Cornell Medical College in New York, New York.
Dr. Jin commented, The primary challenge in the CAR T field is balancing efficacy and toxicity. This grant allows us to continue our work in striking that balance to treat solid tumors by iterating from bench to bedside. In doing so, we can potentially develop the most effective CAR T therapies for solid tumors.
AffyImmune Co-founder Dr Moonsoo Jin Receives Highly Selective R01 Grant from NCI prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
HUNTINGTON â An assistant professor of biomedical sciences at Marshall University was awarded a Research Project Grant by the National Institutes of Health.
Brandon J. Henderson, Ph.D., who is a professor in the Joan C. Edwards School of Medicine, was awarded a $1.86 million five-year grant from the National Institute on Drug Abuse, according to a news release. A Research Project Grant is one of the most competitive grants from the NIH.
The grant was awarded to study the neurobiological and neurophysiological changes that occur due to vaping nicotine in flavored products. Hendersonâs research team will work to better understand how electronic nicotine delivery systems, like vapes, can alter neurobiology to trigger nicotine addiction in adolescents.
E-Mail
IMAGE: Brandon J. Henderson, Ph.D., an assistant professor of biomedical sciences at the Marshall University Joan C. Edwards School of Medicine, has been awarded a $1.86 million Research Project Grant (R01). view more
Credit: Marshall University Joan C. Edwards School of Medicine
HUNTINGTON, W.Va. - Brandon J. Henderson, Ph.D., an assistant professor of biomedical sciences at the Marshall University Joan C. Edwards School of Medicine, has been awarded a Research Project Grant (R01), one of the most competitive grants issued by the National Institutes of Health (NIH).
Henderson was awarded the $1.86 million five-year grant (R01DA050717) from the National Institute on Drug Abuse to study the neurobiological and neurophysiological changes that occur due to vaping nicotine in flavored products. Henderson s research team is working to better understand how electronic nicotine delivery systems, or vaping, alter neurobiology to trigger nicotine addiction in adolescent